Article

Pharmacological and clinical profile of humanized anti-human IL-6 receptor antibody (tocilizumab, ACTEMPA®), a novel therapeutic drug for Castleman's disease

Folia Pharmacologica Japonica
DOI: 10.1254/fpj.126.419
5Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Ohsugi, Y., & Tsuchimoto, N. (2005). Pharmacological and clinical profile of humanized anti-human IL-6 receptor antibody (tocilizumab, ACTEMPA®), a novel therapeutic drug for Castleman’s disease. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.126.419

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free